Senior Clinical Trial Manager
Solid Biosciences
Summary
Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich's ataxia, CPVT, and additional genetic cardiac diseases.
Job description
We are looking for a Senior Clinical Trial Manager to join our Clinical Operations organization. The successful candidate will manage clinical trial activities ensuring the timely completion of deliverables through development, management and oversight of the trial CROs, timeline and budget.
Key Position Responsibilities
- Responsible for effective global management of a clinical study or multiple studies within a clinical development program.
- Responsible for management of the study team for assigned studies or programs and of relationships with CROs, central labs, IRBs, investigating sites and other external partners.
- Coordinates the activities of all trial conduct partners and team members and proactively identifies and manages risks.
- Participate in the development and/or review of all supporting documents for a clinical study, including Protocols, Informed Consent Forms, Investigator Brochures, Study Manuals, Statistical Analysis Plans, CRFs, Data Management Plans and Clinical Study Reports.
- Manage and lead cross-functional clinical trial team meetings.
- Identifies, or assists in identifying, investigational sites and participates in reviewing and approving qualified sites.
- Create and review Request for Proposals, vendor specifications and participate in vendor selection process.
- Manages the negotiation of contracts, budgets, and timelines with CROs, vendors, clinical sites, and other external partners.
- Review study invoices and manage accruals for assigned studies monthly.
- Participates in the coordination of and training team members and external partners.
- Prepare and maintain assigned study and program files, study documentation and other essential documents.
- Provide management with routine updates regarding the status of ongoing studies.
- May participate in internal/external study related audits.
- Ensure compliance to internal processes and GCP.
- Ensure Trial Master File documentation is collected and maintained.
- Attend Investigator Meetings and site visits as needed.
Experience Requirements
- Strong multi-tasking, time management, and organizational skills.
- Ability to take initiative and work both independently and in a team environment.
- Minimum BA/BS Degree.
- Minimum 5 years of clinical trial management experience.
- Must be willing to travel, both domestic and international.
- Demonstrated knowledge and understanding of FDA/EMA/GCP/ICH regulations and guidelines.
- Ability to provide appropriate leadership to clinical sites and CROs.
- Detail-oriented individual with good problem-solving capability.
- Able to travel 10-20% of the time.
Requirements
- Strong multi-tasking, time management, and organizational skills
- Ability to take initiative and work both independently and in a team environment
- Minimum BA/BS Degree
- Minimum 5 years of clinical trial management experience
- Must be willing to travel, both domestic and international
- Demonstrated knowledge and understanding of FDA/EMA/GCP/ICH regulations and guidelines
- Ability to provide appropriate leadership to clinical sites and CROs
- Detail-oriented individual with good problem-solving capability
- Able to travel 10-20% of the time
Benefits
- Health & Dental Insurance
- FSA & HSA
- 401(k) Matching
- Employee Stock Purchase Plan
- Mobile Phone Subsidy
- Tuition Reimbursement
- Vision Coverage
- Life Insurance
- Voluntary Pet Insurance
- Employee Discount Program
- Employee Assistance Programs
- Subsidized Lunch Delivery
- Onsite Gym
- Employee Parking
- 12 Observed Holidays
- Winter Shutdown
- 15-day PTO
- 80-hour PTO Rollover
- 40-hour Sick Policy
- 8 Hour Floating Holiday
Company overview
Solid Biosciences is a precision genetic medicine company focused on developing innovative gene therapies for rare neuromuscular and cardiac diseases. Founded in 2013 and headquartered in Charlestown, Massachusetts, the company has established itself as a leader in the biotechnology research sector with approximately 148 employees. Solid Biosciences' pipeline includes several promising gene therapy candidates targeting devastating conditions such as Duchenne muscular dystrophy (SGT-003), Friedreich's ataxia (SGT-212), catecholaminergic polymorphic ventricular tachycardia (SGT-501), and TNNT2-mediated dilated cardiomyopathy (SGT-601). The company employs a patient-focused approach, having been founded by individuals directly impacted by Duchenne muscular dystrophy, which drives their mission to improve the daily lives of patients living with rare genetic diseases. Beyond therapeutic development, Solid Biosciences is advancing innovative libraries of genetic regulators and enabling technologies designed to significantly impact gene therapy delivery across the industry. The company has raised substantial funding, including a recent $240 million private placement, and trades publicly on the NASDAQ under the symbol SLDB. Their research focuses on uniting experts in science, technology, disease management, and care to develop transformative precision genetic medicines.